Skip to Main Content

Paper Details

Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamsters.
bioRxiv
14
2021
501Y.V1/, ACE2, COVID-19, SARS, SARS-CoV, SARS-CoV-2, SARS-CoV-2 receptor binding domain, mice
Author NameAffiliation
Lauren CarterUniversity of Washington
Lauren CarterInstitute for Protein Design, University of Washington
Charles A WhittakerThe Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Harry KleanthousBill&Melinda Gates Foundation
Neil P KingUniversity of Washington
Neil P KingInstitute for Protein Design, University of Washington
Dan H BarouchRagon Institute of MGH
Dan H BarouchCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School
Dan H BarouchHarvard Medical School
Dan H Barouch
  • 1 - 10

Datasets

Release 1.2